SCHEMBL23587233

SCHEMBL23587233

COC(=O)c1cnn2c(C3CC3)c(Br)ccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SPR P35270 2/20 0.48
▸ HTR2C P28335 1/20 0.41
▸ PLAT P00750 1/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP3A4 P08684 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ HSD17B10 Q99714 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.40
▸ NPC1 O15118 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KEAP1 Q14145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437928 0.85 SPR (0.49) SPRHTR2CPLATKMT2AKDM4E
SCHEMBL25583491 0.85 SPR (0.49) SPRHTR2CPLATKMT2AMEN1
SCHEMBL19128840 0.79 SPR (0.45) SPRHTR2CPLATKDM4EHSD17B10
SCHEMBL17454441 0.77 SPR (0.43) SPRKDM4EHSD17B10ALDH1A1GAA
SCHEMBL19127292 0.77 SPR (0.43) SPRHTR2CPLATKDM4EHSD17B10
SCHEMBL23888976 0.77 PLAT (0.49) SPRHTR2CPLATKMT2ACYP1A2
SCHEMBL19128597 0.77 SPR (0.45) SPRHTR2CPLATKMT2AKDM4E
SCHEMBL23889008 0.77 SPR (0.43) SPRHTR2CPLATKMT2ACYP1A2
SCHEMBL19127243 0.77 SPR (0.43) SPRHTR2CPLATKDM4EHSD17B10
SCHEMBL19128127 0.76 SPR (0.42) SPRHTR2CPLATKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3954681-A1 SPIROHEPTANE SALICYLAMIDES AND RELATED COMPOUNDS AS INHIBITORS OF ROCK Bristol-Myers Squibb Company (US) 2022-02-16 — — EP disclosed
EP-3652168-B1 5-MEMBERED AND BICYCLIC HETEROCYCLIC AMIDES AS INHIBITORS OF ROCK BRISTOL MYERS SQUIBB CO (US) 2021-06-30 — — EP disclosed
Send feedback